The Clorox Company Logo

The Clorox Company

CLX

(3.0)
Stock Price

166,23 USD

2.18% ROA

137.24% ROE

201.61x PER

Market Cap.

17.754.083.490,00 USD

-8656.76% DER

3.33% Yield

1.12% NPM

The Clorox Company Stock Analysis

The Clorox Company Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

The Clorox Company Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (69.43%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-466.31x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-8657%), which means it has a small amount of debt compared to the ownership it holds

4 Dividend Growth

The company's dividend growth has exhibited a remarkable upward trend over the past five years, consistently delivering higher returns to investors.

5 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

6 ROA

The stock's ROA (2.18%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

7 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (6.414), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

8 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

10 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

11 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

The Clorox Company Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

The Clorox Company Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

The Clorox Company Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

The Clorox Company Revenue
Year Revenue Growth
1986 1.089.100.000
1987 1.126.000.000 3.28%
1988 1.259.900.000 10.63%
1989 1.356.300.000 7.11%
1990 1.484.000.000 8.61%
1991 1.646.500.000 9.87%
1992 1.717.000.000 4.11%
1993 1.634.200.000 -5.07%
1994 1.836.900.000 11.03%
1995 1.984.200.000 7.42%
1996 2.217.800.000 10.53%
1997 2.532.700.000 12.43%
1998 2.741.300.000 7.61%
1999 4.003.000.000 31.52%
2000 4.083.000.000 1.96%
2001 3.903.000.000 -4.61%
2002 4.061.000.000 3.89%
2003 4.144.000.000 2%
2004 4.324.000.000 4.16%
2005 4.388.000.000 1.46%
2006 4.644.000.000 5.51%
2007 4.847.000.000 4.19%
2008 5.273.000.000 8.08%
2009 5.450.000.000 3.25%
2010 5.534.000.000 1.52%
2011 5.231.000.000 -5.79%
2012 5.468.000.000 4.33%
2013 5.623.000.000 2.76%
2014 5.591.000.000 -0.57%
2015 5.655.000.000 1.13%
2016 5.761.000.000 1.84%
2017 5.973.000.000 3.55%
2018 6.124.000.000 2.47%
2019 6.214.000.000 1.45%
2020 6.721.000.000 7.54%
2021 7.341.000.000 8.45%
2022 7.107.000.000 -3.29%
2023 7.389.000.000 3.82%
2024 5.544.000.000 -33.28%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

The Clorox Company Research and Development Expenses
Year Research and Development Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 44.800.000 100%
1996 45.800.000 2.18%
1997 50.500.000 9.31%
1998 56.000.000 9.82%
1999 62.000.000 9.68%
2000 63.000.000 1.59%
2001 67.000.000 5.97%
2002 67.000.000 0%
2003 76.000.000 11.84%
2004 84.000.000 9.52%
2005 88.000.000 4.55%
2006 99.000.000 11.11%
2007 108.000.000 8.33%
2008 111.000.000 2.7%
2009 114.000.000 2.63%
2010 119.000.000 4.2%
2011 115.000.000 -3.48%
2012 121.000.000 4.96%
2013 130.000.000 6.92%
2014 125.000.000 -4%
2015 136.000.000 8.09%
2016 141.000.000 3.55%
2017 135.000.000 -4.44%
2018 132.000.000 -2.27%
2019 136.000.000 2.94%
2020 145.000.000 6.21%
2021 149.000.000 2.68%
2022 132.000.000 -12.88%
2023 138.000.000 4.35%
2024 116.000.000 -18.97%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

The Clorox Company General and Administrative Expenses
Year General and Administrative Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 495.000.000 100%
2002 537.000.000 7.82%
2003 532.000.000 -0.94%
2004 552.000.000 3.62%
2005 551.000.000 -0.18%
2006 631.000.000 12.68%
2007 642.000.000 1.71%
2008 690.000.000 6.96%
2009 715.000.000 3.5%
2010 747.000.000 4.28%
2011 735.000.000 -1.63%
2012 798.000.000 7.89%
2013 807.000.000 1.12%
2014 765.000.000 -5.49%
2015 798.000.000 4.14%
2016 806.000.000 0.99%
2017 810.000.000 0.49%
2018 837.000.000 3.23%
2019 856.000.000 2.22%
2020 969.000.000 11.66%
2021 1.004.000.000 3.49%
2022 954.000.000 -5.24%
2023 1.183.000.000 19.36%
2024 1.104.000.000 -7.16%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

The Clorox Company EBITDA
Year EBITDA Growth
1986 195.200.000
1987 187.100.000 -4.33%
1988 236.200.000 20.79%
1989 221.200.000 -6.78%
1990 235.700.000 6.15%
1991 198.100.000 -18.98%
1992 366.200.000 45.9%
1993 382.200.000 4.19%
1994 420.800.000 9.17%
1995 459.000.000 8.32%
1996 537.900.000 14.67%
1997 587.500.000 8.44%
1998 672.200.000 12.6%
1999 1.038.000.000 35.24%
2000 1.041.000.000 0.29%
2001 896.000.000 -16.18%
2002 1.157.000.000 22.56%
2003 1.071.000.000 -8.03%
2004 1.071.000.000 0%
2005 1.036.000.000 -3.38%
2006 966.000.000 -7.25%
2007 1.070.000.000 9.72%
2008 1.120.000.000 4.46%
2009 1.018.000.000 -10.02%
2010 1.068.000.000 4.68%
2011 921.000.000 -15.96%
2012 903.000.000 -1.99%
2013 975.000.000 7.38%
2014 964.000.000 -1.14%
2015 1.021.000.000 5.58%
2016 1.071.000.000 4.67%
2017 1.121.000.000 4.46%
2018 1.139.000.000 1.58%
2019 1.121.000.000 -1.61%
2020 1.284.000.000 12.69%
2021 1.328.000.000 3.31%
2022 713.000.000 -86.26%
2023 773.000.000 7.76%
2024 444.000.000 -74.1%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

The Clorox Company Gross Profit
Year Gross Profit Growth
1986 591.100.000
1987 627.300.000 5.77%
1988 718.100.000 12.64%
1989 758.800.000 5.36%
1990 828.700.000 8.43%
1991 954.600.000 13.19%
1992 1.027.700.000 7.11%
1993 993.000.000 -3.49%
1994 1.110.600.000 10.59%
1995 1.195.900.000 7.13%
1996 1.327.100.000 9.89%
1997 1.535.600.000 13.58%
1998 1.686.400.000 8.94%
1999 2.220.000.000 24.04%
2000 2.034.000.000 -9.14%
2001 1.584.000.000 -28.41%
2002 1.753.000.000 9.64%
2003 1.919.000.000 8.65%
2004 1.937.000.000 0.93%
2005 1.895.000.000 -2.22%
2006 1.959.000.000 3.27%
2007 2.091.000.000 6.31%
2008 2.175.000.000 3.86%
2009 2.346.000.000 7.29%
2010 2.477.000.000 5.29%
2011 2.273.000.000 -8.97%
2012 2.304.000.000 1.35%
2013 2.412.000.000 4.48%
2014 2.360.000.000 -2.2%
2015 2.465.000.000 4.26%
2016 2.598.000.000 5.12%
2017 2.671.000.000 2.73%
2018 2.675.000.000 0.15%
2019 2.728.000.000 1.94%
2020 3.063.000.000 10.94%
2021 3.199.000.000 4.25%
2022 2.545.000.000 -25.7%
2023 2.908.000.000 12.48%
2024 2.128.000.000 -36.65%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

The Clorox Company Net Profit
Year Net Profit Growth
1986 95.600.000
1987 104.900.000 8.87%
1988 132.600.000 20.89%
1989 124.200.000 -6.76%
1990 153.600.000 19.14%
1991 52.700.000 -191.46%
1992 98.700.000 46.61%
1993 167.000.000 40.9%
1994 212.100.000 21.26%
1995 200.800.000 -5.63%
1996 222.100.000 9.59%
1997 249.400.000 10.95%
1998 298.000.000 16.31%
1999 246.000.000 -21.14%
2000 394.000.000 37.56%
2001 323.000.000 -21.98%
2002 322.000.000 -0.31%
2003 493.000.000 34.69%
2004 549.000.000 10.2%
2005 1.096.000.000 49.91%
2006 444.000.000 -146.85%
2007 501.000.000 11.38%
2008 461.000.000 -8.68%
2009 537.000.000 14.15%
2010 603.000.000 10.95%
2011 557.000.000 -8.26%
2012 541.000.000 -2.96%
2013 572.000.000 5.42%
2014 558.000.000 -2.51%
2015 580.000.000 3.79%
2016 648.000.000 10.49%
2017 701.000.000 7.56%
2018 823.000.000 14.82%
2019 820.000.000 -0.37%
2020 939.000.000 12.67%
2021 710.000.000 -32.25%
2022 462.000.000 -53.68%
2023 149.000.000 -210.07%
2024 88.000.000 -69.32%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

The Clorox Company Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 1 0%
1995 1 0%
1996 1 100%
1997 0 0%
1998 1 0%
1999 1 0%
2000 2 100%
2001 1 0%
2002 1 0%
2003 2 50%
2004 3 0%
2005 6 66.67%
2006 3 -200%
2007 3 33.33%
2008 3 0%
2009 4 0%
2010 4 25%
2011 4 0%
2012 4 0%
2013 4 0%
2014 4 0%
2015 4 0%
2016 5 20%
2017 5 0%
2018 6 16.67%
2019 6 0%
2020 7 14.29%
2021 6 -40%
2022 4 -66.67%
2023 1 -200%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

The Clorox Company Free Cashflow
Year Free Cashflow Growth
1989 70.500.000
1990 10.500.000 -571.43%
1991 137.600.000 92.37%
1992 182.000.000 24.4%
1993 167.900.000 -8.4%
1994 210.200.000 20.12%
1995 227.900.000 7.77%
1996 321.900.000 29.2%
1997 266.900.000 -20.61%
1998 65.300.000 -308.73%
1999 296.000.000 77.94%
2000 500.000.000 40.8%
2001 555.000.000 9.91%
2002 699.000.000 20.6%
2003 598.000.000 -16.89%
2004 727.000.000 17.74%
2005 614.000.000 -18.4%
2006 342.000.000 -79.53%
2007 562.000.000 39.15%
2008 560.000.000 -0.36%
2009 541.000.000 -3.51%
2010 616.000.000 12.18%
2011 470.000.000 -31.06%
2012 420.000.000 -11.9%
2013 581.000.000 27.71%
2014 629.000.000 7.63%
2015 749.000.000 16.02%
2016 606.000.000 -23.6%
2017 637.000.000 4.87%
2018 780.000.000 18.33%
2019 786.000.000 0.76%
2020 1.292.000.000 39.16%
2021 945.000.000 -36.72%
2022 535.000.000 -76.64%
2023 930.000.000 42.47%
2024 -4.000.000 23350%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

The Clorox Company Operating Cashflow
Year Operating Cashflow Growth
1989 158.300.000
1990 166.400.000 4.87%
1991 246.700.000 32.55%
1992 306.700.000 19.56%
1993 245.500.000 -24.93%
1994 266.800.000 7.98%
1995 290.800.000 8.25%
1996 406.700.000 28.5%
1997 362.100.000 -12.32%
1998 312.700.000 -15.8%
1999 588.000.000 46.82%
2000 658.000.000 10.64%
2001 747.000.000 11.91%
2002 876.000.000 14.73%
2003 803.000.000 -9.09%
2004 899.000.000 10.68%
2005 765.000.000 -17.52%
2006 522.000.000 -46.55%
2007 709.000.000 26.38%
2008 730.000.000 2.88%
2009 738.000.000 1.08%
2010 819.000.000 9.89%
2011 698.000.000 -17.34%
2012 612.000.000 -14.05%
2013 775.000.000 21.03%
2014 767.000.000 -1.04%
2015 874.000.000 12.24%
2016 778.000.000 -12.34%
2017 868.000.000 10.37%
2018 974.000.000 10.88%
2019 992.000.000 1.81%
2020 1.546.000.000 35.83%
2021 1.276.000.000 -21.16%
2022 786.000.000 -62.34%
2023 1.158.000.000 32.12%
2024 20.000.000 -5690%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

The Clorox Company Capital Expenditure
Year Capital Expenditure Growth
1989 87.800.000
1990 155.900.000 43.68%
1991 109.100.000 -42.9%
1992 124.700.000 12.51%
1993 77.600.000 -60.7%
1994 56.600.000 -37.1%
1995 62.900.000 10.02%
1996 84.800.000 25.83%
1997 95.200.000 10.92%
1998 247.400.000 61.52%
1999 292.000.000 15.27%
2000 158.000.000 -84.81%
2001 192.000.000 17.71%
2002 177.000.000 -8.47%
2003 205.000.000 13.66%
2004 172.000.000 -19.19%
2005 151.000.000 -13.91%
2006 180.000.000 16.11%
2007 147.000.000 -22.45%
2008 170.000.000 13.53%
2009 197.000.000 13.71%
2010 203.000.000 2.96%
2011 228.000.000 10.96%
2012 192.000.000 -18.75%
2013 194.000.000 1.03%
2014 138.000.000 -40.58%
2015 125.000.000 -10.4%
2016 172.000.000 27.33%
2017 231.000.000 25.54%
2018 194.000.000 -19.07%
2019 206.000.000 5.83%
2020 254.000.000 18.9%
2021 331.000.000 23.26%
2022 251.000.000 -31.87%
2023 228.000.000 -10.09%
2024 24.000.000 -850%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

The Clorox Company Equity
Year Equity Growth
1986 549.800.000
1987 616.400.000 10.8%
1988 712.900.000 13.54%
1989 786.200.000 9.32%
1990 810.500.000 3%
1991 784.300.000 -3.34%
1992 813.700.000 3.61%
1993 879.300.000 7.46%
1994 909.400.000 3.31%
1995 943.900.000 3.66%
1996 932.800.000 -1.19%
1997 1.036.000.000 9.96%
1998 1.085.200.000 4.53%
1999 1.570.000.000 30.88%
2000 1.794.000.000 12.49%
2001 1.900.000.000 5.58%
2002 1.354.000.000 -40.32%
2003 1.215.000.000 -11.44%
2004 1.540.000.000 21.1%
2005 -553.000.000 378.48%
2006 -156.000.000 -254.49%
2007 171.000.000 191.23%
2008 -370.000.000 146.22%
2009 -175.000.000 -111.43%
2010 83.000.000 310.84%
2011 -86.000.000 196.51%
2012 -135.000.000 36.3%
2013 146.000.000 192.47%
2014 154.000.000 5.19%
2015 118.000.000 -30.51%
2016 297.000.000 60.27%
2017 542.000.000 45.2%
2018 726.000.000 25.34%
2019 559.000.000 -29.87%
2020 908.000.000 38.44%
2021 592.000.000 -53.38%
2022 729.000.000 18.79%
2023 388.000.000 -87.89%
2024 131.000.000 -196.18%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

The Clorox Company Assets
Year Assets Growth
1986 849.200.000
1987 933.300.000 9.01%
1988 1.156.000.000 19.26%
1989 1.213.100.000 4.71%
1990 1.137.700.000 -6.63%
1991 1.602.700.000 29.01%
1992 1.614.800.000 0.75%
1993 1.649.200.000 2.09%
1994 1.697.600.000 2.85%
1995 1.906.700.000 10.97%
1996 2.178.900.000 12.49%
1997 2.778.000.000 21.57%
1998 3.030.000.000 8.32%
1999 4.132.000.000 26.67%
2000 4.353.000.000 5.08%
2001 3.995.000.000 -8.96%
2002 3.630.000.000 -10.06%
2003 3.652.000.000 0.6%
2004 3.834.000.000 4.75%
2005 3.617.000.000 -6%
2006 3.616.000.000 -0.03%
2007 3.666.000.000 1.36%
2008 4.708.000.000 22.13%
2009 4.576.000.000 -2.88%
2010 4.555.000.000 -0.46%
2011 4.163.000.000 -9.42%
2012 4.355.000.000 4.41%
2013 4.311.000.000 -1.02%
2014 4.258.000.000 -1.24%
2015 4.164.000.000 -2.26%
2016 4.518.000.000 7.84%
2017 4.573.000.000 1.2%
2018 5.060.000.000 9.62%
2019 5.116.000.000 1.09%
2020 6.213.000.000 17.66%
2021 6.334.000.000 1.91%
2022 6.158.000.000 -2.86%
2023 5.945.000.000 -3.58%
2024 5.991.000.000 0.77%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

The Clorox Company Liabilities
Year Liabilities Growth
1986 299.400.000
1987 316.900.000 5.52%
1988 443.100.000 28.48%
1989 426.900.000 -3.79%
1990 327.200.000 -30.47%
1991 818.400.000 60.02%
1992 801.100.000 -2.16%
1993 769.900.000 -4.05%
1994 788.200.000 2.32%
1995 962.800.000 18.13%
1996 1.246.100.000 22.73%
1997 1.742.000.000 28.47%
1998 1.944.800.000 10.43%
1999 2.562.000.000 24.09%
2000 2.559.000.000 -0.12%
2001 2.095.000.000 -22.15%
2002 2.276.000.000 7.95%
2003 2.437.000.000 6.61%
2004 2.294.000.000 -6.23%
2005 4.170.000.000 44.99%
2006 3.772.000.000 -10.55%
2007 3.495.000.000 -7.93%
2008 5.078.000.000 31.17%
2009 4.751.000.000 -6.88%
2010 4.472.000.000 -6.24%
2011 4.249.000.000 -5.25%
2012 4.490.000.000 5.37%
2013 4.165.000.000 -7.8%
2014 4.104.000.000 -1.49%
2015 4.046.000.000 -1.43%
2016 4.221.000.000 4.15%
2017 4.031.000.000 -4.71%
2018 4.334.000.000 6.99%
2019 4.557.000.000 4.89%
2020 5.305.000.000 14.1%
2021 5.742.000.000 7.61%
2022 5.429.000.000 -5.77%
2023 5.557.000.000 2.3%
2024 5.860.000.000 5.17%

The Clorox Company Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
56.75
Net Income per Share
0.71
Price to Earning Ratio
201.61x
Price To Sales Ratio
2.52x
POCF Ratio
17.74
PFCF Ratio
22.36
Price to Book Ratio
-479.51
EV to Sales
2.91
EV Over EBITDA
27.4
EV to Operating CashFlow
20.44
EV to FreeCashFlow
25.74
Earnings Yield
0
FreeCashFlow Yield
0.04
Market Cap
17,75 Bil.
Enterprise Value
20,44 Bil.
Graham Number
2.18
Graham NetNet
-36.71

Income Statement Metrics

Net Income per Share
0.71
Income Quality
10.1
ROE
0.69
Return On Assets
0.01
Return On Capital Employed
0.38
Net Income per EBT
0.52
EBT Per Ebit
0.11
Ebit per Revenue
0.2
Effective Tax Rate
0.41

Margins

Sales, General, & Administrative to Revenue
0.17
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.42
Operating Profit Margin
0.2
Pretax Profit Margin
0.02
Net Profit Margin
0.01

Dividends

Dividend Yield
0.03
Dividend Yield %
3.33
Payout Ratio
6.67
Dividend Per Share
4.76

Operating Metrics

Operating Cashflow per Share
8.07
Free CashFlow per Share
6.4
Capex to Operating CashFlow
-0.21
Capex to Revenue
-0.03
Capex to Depreciation
-0.85
Return on Invested Capital
0.2
Return on Tangible Assets
0.02
Days Sales Outstanding
30.14
Days Payables Outstanding
145.1
Days of Inventory on Hand
61.4
Receivables Turnover
12.11
Payables Turnover
2.52
Inventory Turnover
5.95
Capex per Share
-1.66

Balance Sheet

Cash per Share
4,18
Book Value per Share
-0,30
Tangible Book Value per Share
-14.66
Shareholders Equity per Share
-0.3
Interest Debt per Share
26.55
Debt to Equity
-86.57
Debt to Assets
0.53
Net Debt to EBITDA
3.6
Current Ratio
0.86
Tangible Asset Value
-1,82 Bil.
Net Current Asset Value
-3,95 Bil.
Invested Capital
-86.57
Working Capital
-0,32 Bil.
Intangibles to Total Assets
0.33
Average Receivables
0,63 Bil.
Average Payables
1,67 Bil.
Average Inventory
703000000
Debt to Market Cap
0.18

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

The Clorox Company Dividends
Year Dividends Growth
1973 1
1983 1 0%
1984 1 100%
1985 1 0%
1986 1 0%
1987 1 0%
1988 1 100%
1989 1 0%
1990 1 0%
1991 2 0%
1992 2 0%
1993 2 0%
1994 2 0%
1995 2 50%
1996 2 0%
1997 2 0%
1998 1 -100%
1999 1 0%
2000 1 0%
2001 1 0%
2002 1 0%
2003 1 0%
2004 1 100%
2005 1 0%
2006 1 0%
2007 1 0%
2008 2 0%
2009 2 0%
2010 2 50%
2011 2 0%
2012 2 0%
2013 3 0%
2014 3 0%
2015 3 33.33%
2016 3 0%
2017 3 0%
2018 4 0%
2019 4 25%
2020 4 0%
2021 5 0%
2022 5 0%
2023 5 0%

The Clorox Company Profile

About The Clorox Company

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.

CEO
Ms. Linda Rendle
Employee
8.700
Address
1221 Broadway
Oakland, 94612-1888

The Clorox Company Executives & BODs

The Clorox Company Executives & BODs
# Name Age
1 Ms. Chau Banks
Senior Vice President and Chief Information & Enterprise Data Officer
70
2 Ms. Kirsten M. Marriner
Executive Vice President and Chief People & Corporate Affairs Officer
70
3 Ms. Laura E. Peck
Vice President, Chief Accounting Officer & Corporate Controller
70
4 Ms. Linda Rendle
Chief Executive Officer & Chairman
70
5 Mr. Eric H. Reynolds
Executive Vice President & Chief Operating and Strategy Officer
70
6 Ms. Stacey Grier
Executive Vice President and Executive Chief of Staff
70
7 Mr. Kevin B. Jacobsen
Executive Vice President & Chief Financial Officer
70
8 Lisah Burhan
Vice President of Investor Relations
70
9 Ms. Angela C. Hilt
Executive Vice President & Chief Legal Officer
70
10 Mr. Eric Sean Schwartz
Senior Vice President & Chief Marketing Officer
70

The Clorox Company Competitors